CME Group (CME) Revenue — Quarter Ended Sep 30, 2025
Revenue for the reported quarter declined compared to the preceding quarter. It also fell relative to the same period last year.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the reported quarter declined compared to the preceding quarter. It also fell relative to the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.5B
Revenue reported for this quarter.
Quarter-over-quarter
-9.1%
Change from the immediately preceding quarter.
Year-over-year
-3.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$6.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $1.5B | +6.0% |
| Mar 31, 2025 | $1.6B | +10.4% |
| Jun 30, 2025 | $1.7B | +10.4% |
| Sep 30, 2025 | $1.5B | -3.0% |
Revenue performance
Revenue declined from the prior quarter and from the year-ago quarter.
Quarterly comparison
Net cash from operating activities for the first nine months of the year rose, partly attributed to higher trading volume and interest income on collateral reinvestment.
What to watch
The company's outstanding debt and revolving credit facility represent a significant liquidity position; changes in interest rates or market conditions could influence future financial results.